Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Boccaletto, P. et al. Nucleic Acids Res. 46, D303–D307 (2018).
Shi, H., Wei, J. & He, C. Mol. Cell 74, 640–650 (2019).
Akichika, S. et al. Science 363, eaav0080 (2019).
Boulias, K. et al. Mol. Cell 75, 631–643 e638 (2019).
Sendinc, E. et al. Mol. Cell 75, 620–630 e629 (2019).
Sun, H., Zhang, M., Li, K., Bai, D. & Yi, C. Cell Res. 29, 80–82 (2019).
Mauer, J. et al. Nat. Chem. Biol. 15, 340–347 (2019).
Bujnicki, J. M., Feder, M., Radlinska, M. & Blumenthal, R. M. J. Mol. Evol. 55, 431–444 (2002).
Ma, C. et al. Nat. Cell Biol. 21, 319–327 (2019).
Kweon, S. M. et al. Mol. Cell 74, 1138–1147 e1136 (2019).
Greer, E. L. et al. Cell 161, 868–878 (2015).
Wei, J. et al. Mol. Cell 71, 973–985 e975 (2018).
Reddy, R., Henning, D., Epstein, P. & Busch, H. Nucleic Acids Res. 9, 5645–5658 (1981).
Lee, Y. & Rio, D. C. Annu. Rev. Biochem. 84, 291–323 (2015).
Acknowledgements
We thank Chunmei Li, Matthew Harris, Erdem Sendinc, and David Valle-Garcia for insightful advice. Y.S. is supported by BCH funds. R.I.G. is a recipient of the NCI Outstanding Investigator Award (R35 CA232115-01). E.A.O. was supported by the Pew Latin American Fellows Program and by a Damon Runyon Fellowship (DRG-2378-19). Y.X. is supported by NIH grants (R01GM088342 and R01GM121827). Y.S. is an American Cancer Society Research Professor.
Author information
Authors and Affiliations
Contributions
Y.S. and H.C. conceived and designed the project. H.C., L.G., J.G. and Q.L. carried out most of the biochemical and cellular experiments. Y.W. performed the bioinformatic analysis under supervision of Y.X. E.A.O. performed m6A Northwestern analysis under supervision of R.I.G. L.W. and Z.S. contributed to characterization of enzymatic activity under supervision of H.W. Y.S. supervised the project throughout. Y.S. and H.C. co-wrote the manuscript and all authors contributed to manuscript writing.
Corresponding author
Ethics declarations
Competing interests
R.I.G. is a co-founder, scientific advisory board member, and equity holder of 28-7 Therapeutics. Y.X. is a scientific cofounder of Panorama Medicine. Y.S. is a co-founder and equity holder of Constellation Pharmaceuticals, Inc., a consultant of Guangzhou BeBetter Medicine Technology Co., LTD and an equity holder of Imago Biosciences. All other authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Chen, H., Gu, L., Orellana, E.A. et al. METTL4 is an snRNA m6Am methyltransferase that regulates RNA splicing. Cell Res 30, 544–547 (2020). https://doi.org/10.1038/s41422-019-0270-4
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41422-019-0270-4
This article is cited by
-
Biological roles of enhancer RNA m6A modification and its implications in cancer
Cell Communication and Signaling (2025)
-
Correlation of METTL4 genetic variants and severe pneumonia pediatric patients in Southern China
BMC Genomic Data (2025)
-
Mechanism for the substrate recognition by a eukaryotic DNA N6-adenine methyltransferase complex
Nature Communications (2025)
-
The diverse landscape of RNA modifications in cancer development and progression
Genes & Genomics (2025)
-
Small molecule inhibitors targeting m6A regulators
Journal of Hematology & Oncology (2024)
